Phylogica patent allowed

By Ruth Beran
Thursday, 29 September, 2005

Perth-based Phylogica (ASX:PYC) has received formal notice of allowance from the European Patent and Trademark Office for its pending patent application entitled: "Isolating biological modulators from biodiverse gene fragment libraries".

The application was filed in 2000 and protects Phylogica's core peptide library technology. Phylogica's proprietary libraries contain millions of phylomers - stable fragments of naturally occurring proteins.

"Not only are the methods for creating these libraries covered but this foundation patent application also describes methods for increasing the diversity of the libraries further," said Phylogica's scientific director Dr Paul Watt in a statement.

Phylogica has eight patent families and cases from the patent family of this recently allowed application have already been granted in Australia and allowed in the US.

Related News

More effective antibiotic found for Lyme disease

Researchers have found that piperacillin, an antibiotic in the same class as penicillin,...

Why do our waistlines expand in middle age?

A new preclinical study highlights the importance of controlling new fat-cell formation to...

Anti-inflammatory drug may help treat alcohol use disorder

A drug that is already FDA-approved for treating inflammatory conditions may help reduce both...


  • All content Copyright © 2025 Westwick-Farrow Pty Ltd